Details for New Drug Application (NDA): 071789
✉ Email this page to a colleague
NDA 071789 describes GEN-XENE, which is a drug marketed by Alra and is included in three NDAs. Additional details are available on the GEN-XENE profile page.
The generic ingredient in GEN-XENE is clorazepate dipotassium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.
The generic ingredient in GEN-XENE is clorazepate dipotassium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.
Summary for 071789
| Tradename: | GEN-XENE |
| Applicant: | Alra |
| Ingredient: | clorazepate dipotassium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 071789
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
| Approval Date: | Apr 26, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
